| Test No. |
Test Type |
Test name |
Test Outline |
| JCOG1910A1 |
Accompanying Research |
An Exploratory Study on Prognostic Biomarkers in Elderly Patients with Primary Glioblastoma |
|
| JCOG1910 |
Phase III trials |
A Randomized, Controlled Phase III Study of Oligofractionated Radiotherapy with Temozolomide for Elderly Patients with Primary Glioblastoma |
|
| JCOG1703 |
Phase III trials |
A Randomized Phase III Trial of Radical Ablation + Implantation of Carmustine for Intracerebral Implantation + Temozolomide Chemoradiation versus Radical Ablation + Temozolomide Chemoradiation for Primary Glioblastoma |
|
| JCOG1308C |
Phase III trials |
A Multicenter, Randomized Phase III Trial Comparing Dose-Enhanced Temozolomide + Bevacizab Therapy in Recurrent Glioblastoma |
|
| JCOG1303B |
Individual Banking |
JCOG-Biobank Japan collaborative biobank Frozen tissue and blood banking of patients enrolled in JCOG1303 |
|
| JCOG1303 |
Phase III trials |
A Randomized Phase III Trial Comparing Radiation Alone and Radiation Therapy with Temozolomide for WHO Grade II Astrocytoma with Residual Tumor after Surgery |
|
| JCOG1114CA1 |
Accompanying Research |
An exploratory study of PCNSL prognostic biomarkers and determinants of response to therapy by analysis of clinical specimens |
|
| JCOG1114C |
Phase III trials |
A randomized controlled trial of preirradiation high-dose methotrexate plus radiotherapy versus preirradiation high-dose methotrexate plus concomitant radiotherapy with temozolomide plus maintenance temozolomide for first primary malignant lymphoma of the central nervous system |
|
| JCOG1016B |
Individual Banking |
JCOG-Biobank Japan collaborative biobank Frozen tissue and blood banking of patients enrolled in JCOG1016 |
|
| JCOG1016 |
Phase III trials |
A Randomized Phase III Trial Comparing Postoperative Nimustine Hydrochloride (ACNU) Chemoradiation with Temozolomide Chemoradiation at Prior Recurrence in Primary Anaplastic Glioma |
|
| JCOG0911A2 |
Accompanying Research |
A study of MRI-based treatment response and MRI-based prognosis prediction for glioblastoma treated with chemoradiotherapy |
|
| JCOG0911A1 |
Accompanying Research |
A Study of Predictive and Prognostic Factors in Glioblastoma Patients Treated with Chemotherapy and Radiation Therapy |
|
| JCOG0911 |
Randomized phase II trial |
A Randomized Phase II Trial of Interferon-beta plus Temozolomide Chemoradiotherapy for Primary Glioblastoma |
|
| JCOG0504 |
Phase III trials |
A Randomized Comparison of Tumor Resection + Whole Brain Irradiation versus Tumor Resection + Salvage Radiation Therapy for Metastatic Brain Tumors |
|
| JCOG0305 |
Phase II/III trials |
A Randomized Phase II/III Study of ACNU Alone vs. Procarbazine + ACNU Combination as Radiochemotherapy for Grades 3 and 4 Astrocytoma |
|
